ImmuCell

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell ImmuCell and other ETFs, options, and stocks.

About ICCC

ImmuCell Corp. engages in the development, acquisition, manufacture, and sale of products that improve the health and productivity of cows for the dairy and beef industries. Its products include first defense for scours, California mastitis test kits, and purified nisin intramammary treatment for mastitis. 

CEO
Olivier te Boekhorst
CEOOlivier te Boekhorst
Employees
75
Employees75
Headquarters
Portland, Maine
HeadquartersPortland, Maine
Founded
1982
Founded1982
Employees
75
Employees75

ICCC Key Statistics

Market cap
55.18M
Market cap55.18M
Price-Earnings ratio
23.64
Price-Earnings ratio23.64
Dividend yield
Dividend yield
Average volume
42.74K
Average volume42.74K
High today
$7.12
High today$7.12
Low today
$5.12
Low today$5.12
Open price
$6.00
Open price$6.00
Volume
336.41K
Volume336.41K
52 Week high
$7.60
52 Week high$7.60
52 Week low
$4.28
52 Week low$4.28

Stock Snapshot

The current ImmuCell(ICCC) stock price is $6.09, with a market capitalization of 55.18M. The stock trades at a price-to-earnings (P/E) ratio of 23.64.

During the trading session on 2025-12-28, ImmuCell(ICCC) shares reached a daily high of $7.12 and a low of $5.12. At a current price of $6.09, the stock is +19.0% higher than the low and still -14.5% under the high.

Trading activity shows a volume of 336.41K, compared to an average daily volume of 42.74K.

Over the past 52 weeks, ImmuCell(ICCC) stock has traded between a high of $7.60 and a low of $4.28.

Over the past 52 weeks, ImmuCell(ICCC) stock has traded between a high of $7.60 and a low of $4.28.

ICCC News

Benzinga 2d
ImmuCell Puts Re-Tain On Pause After FDA Letter

Animal health firm ImmuCell Corporation (NASDAQ:ICCC) received an Incomplete Letter from the United States Food and Drug Administration (FDA) on Tuesday for its...

TipRanks 4d
Immucell to pause further investment in Re-Tain after FDA Incomplete Letter

ImmuCell (ICCC) Corporation announced that it received an Incomplete Letter from the FDA on December 23 for its Re-Tain New Animal Drug Application, or NADA, an...

People also own

Based on the portfolios of people who own ICCC. This list is generated using Robinhood data, and it’s not a recommendation.
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.